Lifeward

Lifeward EBIT Growth

The Year-over-Year EBIT Growth of Lifeward (LFWD) as of Nov 22, 2026 is 0.11 %. In the previous year, Year-over-Year EBIT Growth was 17.19 % — a change of -99.38% (lower).

EBIT Growth

0.11 %

YoY

-99.38%

Last updated:

Year-over-Year EBIT Growth of Lifeward is 2025 0.11 % . Year-over-Year EBIT Growth of Lifeward was 2024 17.19 % . It decreases by -99.38% lower compared to the previous year.

The Lifeward EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2018
12.63 USD
Jan 1, 2019
26.89 USD
Jan 1, 2020
14.45 USD
Jan 1, 2021
-5.30 USD
Jan 1, 2022
-50.94 USD
Jan 1, 2023
-23.61 USD
Jan 1, 2024
17.19 USD
Jan 1, 2025
0.11 USD
The Lifeward EBIT Growth history
YEAREBIT GrowthYoY
0.11 %-99.38%
17.19 %-172.81%
-23.61 %-53.66%
-50.94 %+861.14%
-5.30 %-136.68%
14.45 %-46.25%
26.89 %+112.85%
12.63 %-54.49%
27.76 %-232.66%
-20.92 %-20.58%
-26.34 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

Year-over-Year EBIT Growth of Lifeward is 0.11 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Lifeward since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Lifeward historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Lifeward

All Key Metrics — Lifeward